The table below shows the List Of Top 10 Pharma Companies based on market cap.
| Name | Market Cap ( Cr ) | Close Price |
| Sun Pharmaceutical Industries Ltd | 359804.27 | 1534.80 |
| Cipla Ltd | 114661.20 | 1439.75 |
| Dr Reddy’s Laboratories Ltd | 102573.06 | 6155.85 |
| Mankind Pharma Ltd | 90122.38 | 2241.85 |
| Torrent Pharmaceuticals Ltd | 89549.28 | 2657.35 |
| Zydus Lifesciences Ltd | 81183.83 | 805.05 |
| Lupin Ltd | 73169.74 | 1622.10 |
| Alkem Laboratories Ltd | 63502.76 | 5327.90 |
| Abbott India Ltd | 60046.92 | 28083.70 |
| Aurobindo Pharma Ltd | 58746.20 | 1003.15 |
The pharmaceutical sector in India is primarily involved in the research, development, manufacturing, and marketing of pharmaceutical products such as drugs, medicines, vaccines, and medical devices for domestic and international markets.
Content:
- Top 10 Pharma Companies By Market Cap In India
- Introduction to Top Pharma Companies In India By Market Cap
- Highest Market Cap Pharmaceutical Companies In India – FAQ
Top 10 Pharma Companies By Market Cap In India
Sun Pharmaceutical Industries Ltd
Sun Pharmaceutical Industries Ltd, with a market capitalization of 359,804.27 crores, has a PE ratio of 42.46. Its one-year return stands at 52.44%. Additionally, it is currently trading at 0.27% below its 52-week high.
Sun Pharmaceutical Industries Limited, an Indian specialty generic pharmaceutical firm, manufactures, develops, and markets branded and generic formulations and active pharmaceutical ingredients (APIs).
Its diverse portfolio encompasses medicines for chronic and acute treatments, including oncology, hormones, peptides, and steroidal drugs. With offerings like Ilumya/Ilumetri and Winlevi, Sun Pharma caters to various markets with various dosage forms.
Cipla Ltd
Cipla Ltd has a market capitalization of 114,661.20 crores and a PE ratio of 40.92. Over the past year, it has recorded a return of 40.94%. The stock is trading at approximately 1.25% below its 52-week high.
Cipla Limited, an Indian pharmaceutical company, operates in two segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment focuses on developing, manufacturing, and distributing generic or branded medicines and APIs.
The New Ventures segment includes consumer healthcare, biosimilars, and specialty businesses. Cipla’s product portfolio spans various therapeutic areas across multiple geographical segments.
Dr Reddy’s Laboratories Ltd
Dr. Reddy’s Laboratories Ltd has a market capitalization of 102,573.06 crores and a PE ratio of 22.76. Over the past year, it has delivered a return of 37.18%. Presently, the stock is trading approximately 1.04% below its 52-week high.
Dr. Reddy’s Laboratories Limited is an Indian pharmaceutical company with a global presence, offering various products and services such as APIs, generics, biosimilars, and OTC medications. Its focus areas include gastrointestinal, cardiovascular, and oncology treatments.
The company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others.
Mankind Pharma Ltd
Mankind Pharma Ltd has a market capitalization of 90,122.38 crores and a PE ratio of 70.31. Over the past year, it has yielded a return of 57.62%. Currently, the stock is trading around 2.48% below its 52-week high.
Mankind Pharma Limited, an Indian pharmaceutical company, specializes in developing, manufacturing, and marketing pharmaceutical formulations across diverse therapeutic areas, including acute and chronic conditions.
Its portfolio encompasses anti-infectives, cardiovascular, gastrointestinal, respiratory, dermatology, and other segments, with notable brands like Nurokind, Telmikind, and Manforce (Rx).
Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd has a market capitalization of 89,549.28. Its PE ratio is 71.91, with a one-year return of 72.53%. The stock is trading approximately 1.60% lower than its 52-week high.
Torrent Pharmaceuticals Limited, an Indian pharmaceutical firm, focuses on therapeutic segments like cardiovascular, central nervous system, gastrointestinal, and vitamins. Engaged in research, development, manufacturing, and distribution of pharmaceutical formulations globally, its product brands range from pediatric care like Tedibar to dermatology products like Clinmiskin.
With manufacturing units in Gujarat, Himachal Pradesh, and other states, its distribution network spans wholesale distributors, stockists, and retail pharmacies.
Zydus Lifesciences Ltd
Zydus Lifesciences Ltd has a market capitalization of 81,183.83. Its PE ratio is 41.41, with a one-year return of 69.70%. The stock is trading approximately 1.98% lower than its 52-week high.
Zydus Lifesciences Ltd., an Indian life sciences firm, focuses on researching, developing, manufacturing, and marketing of various products. These include finished dosage human formulations like generics, biosimilars, vaccines, APIs, animal healthcare, and consumer wellness items. Key offerings include Bilypsa, Oxemia, Ujvira, and Exemptia, catering to diverse medical needs.
Lupin Ltd
Lupin Ltd’s market capitalization stands at 73,169.74. With a PE ratio of 170.13, it has seen a one-year return of 109.48%. Currently, the stock is trading approximately 4.80% below its 52-week high.
Lupin Limited, an Indian pharmaceutical company, specializes in manufacturing, developing, and marketing branded and generic formulations, biotechnology products, and APIs worldwide. It operates in various therapy segments like Cardiovascular, Diabetology, and Gastro-Intestinal.
With manufacturing facilities in India, the USA, Mexico, and Brazil, Lupin offers complex generics such as Filgrastim and biosimilars like Lupifil and Lupifil-P.
Alkem Laboratories Ltd
Alkem Laboratories Ltd has a market capitalization of 63,502.76. With a PE ratio of 64.52, it has achieved a one-year return of 64.93%. Presently, the stock is trading approximately 1.73% below its 52-week high.
Alkem Laboratories Limited, an Indian pharmaceutical company with global operations, specializes in developing, manufacturing, and selling pharmaceutical and nutraceutical products. Its diverse product portfolio spans therapeutic areas like infection, Dermatology, Cardiology, and more.
With approximately 21 manufacturing facilities in India and the US, it distributes around 800 brands across 40 countries.
Abbott India Ltd
Abbott India Ltd has a market capitalization of 60,046.92. With a PE ratio of 63.25, it has achieved a one-year return of 34.72%. Currently, the stock is trading approximately 2.72% below its 52-week high.
Abbott India Limited, an Indian pharmaceutical company, offers various healthcare solutions, including diagnostics, medical devices, nutrition products, and generic medicines. Its portfolio covers therapeutic areas like women’s health, gastroenterology, and CNS disorders.
Popular products include Colospa, Ganaton, and Librax, marketed under brands like Similac and Ensure.
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd has a market capitalization of 58,746.20. With a PE ratio of 30.48, it has achieved an impressive one-year return of 127.50%. Presently, the stock is trading approximately 17.34% below its 52-week high.
Aurobindo Pharma Limited, an Indian pharmaceutical firm, primarily manufactures and markets active pharmaceutical ingredients and branded and generic drugs across seven therapeutic areas, including CNS, ARVs, CVS, SSP, anti-infectives, anti-diabetics, and cephalosporins. It develops oncology, hormonal, dermatology products, and depot injections utilizing microsphere and nano-suspension technology.
With subsidiaries like APL Healthcare Limited, Auronext Pharma Private Limited, and others, it markets products globally in about 150 countries.
Highest Market Cap Pharmaceutical Companies In India – FAQ
Which are the top pharma companies based on market cap?
High market capitalization can be advantageous for stocks, indicating stability, liquidity, and investor confidence.
Highest Market Cap Pharmaceutical Companies #1: Sun Pharmaceutical Industries Ltd
Highest Market Cap Pharmaceutical Companies #2: Cipla Ltd
Highest Market Cap Pharmaceutical Companies #3: Dr Reddy’s Laboratories Ltd
Highest Market Cap Pharmaceutical Companies #4: Mankind Pharma Ltd
Highest Market Cap Pharmaceutical Companies #5: Torrent Pharmaceuticals Ltd
The stocks mentioned are ranked according to the highest market capitalization.
Is it good to invest in pharma stocks?
Investing in pharma stocks can be beneficial due to potential growth opportunities and resilience, but risks exist, including regulatory changes and drug pipeline challenges.
What is the future of pharma stocks?
The future of pharma stocks appears promising due to ongoing innovations, increasing healthcare spending, and rising demand for healthcare products globally.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
